American Family Children's Hospital
SHARE TEXT
Carey E. Gleason, PhD close
Carey E. Gleason, PhD


For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Carey E. Gleason, PhD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Carey E. Gleason, PhD completed her education at the California School of Professional Psychology.

Specialties

Geriatrics (Specialty Care)

UW Health Clinics

University Station Clinic
(608) 263-7740 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital (primary)
Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Education California School of Professional Psychology, Fresno
Fellowship

Geropsychology Fellowship, Loius Stokes Cleveland Veterans Administrations Medical Center, Cleveland, OH; Neuropsychology Fellowship; University of Washington, Geriatric Research, Education and Clinical Center (GRECC), Tacoma, WA



Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Programs & Conditions

PubMed Articles
Messina M Gleason C . Evaluation of the potential antidepressant effects of soybean isoflavones. Menopause. 2016 Dec;23(12):1348-1360
[PubMed ID: 27552470]
Koscik RL Berman SE Clark LR Mueller KD Okonkwo OC Gleason CE Hermann BP Sager MA Johnson SC . Intraindividual Cognitive Variability in Middle Age Predicts Cognitive Impairment 8-10 Years Later: Results from the Wisconsin Registry for Alzheimer's Prevention. J Int Neuropsychol Soc. 2016 Nov;22(10):1016-1025
[PubMed ID: 27903330]
Santoro N Allshouse A Neal-Perry G Pal L Lobo RA Naftolin F Black DM Brinton EA Budoff MJ Cedars MI Dowling NM Dunn M Gleason CE Hodis HN Isaac B Magnani M Manson JE Miller VM Taylor HS Wharton W Wolff E Zepeda V Harman SM . Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause. 2016 Oct 24;
[PubMed ID: 27779568]
Kantarci K Tosakulwong N Lesnick TG Zuk SM Gunter JL Gleason CE Wharton W Dowling NM Vemuri P Senjem ML Shuster LT Bailey KR Rocca WA Jack CR Jr Asthana S Miller VM . Effects of hormone therapy on brain structure: A randomized controlled trial. Neurology. 2016 Aug 30;87(9):887-96
[PubMed ID: 27473135]
Racine AM Koscik RL Berman SE Nicholas CR Clark LR Okonkwo OC Rowley HA Asthana S Bendlin BB Blennow K Zetterberg H Gleason CE Carlsson CM Johnson SC . Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife. Brain. 2016 Aug;139(Pt 8):2261-74
[PubMed ID: 27324877]
Gleason CE Dowling NM Benton SF Kaseroff A Gunn W Edwards DF . Common Sense Model Factors Affecting African Americans' Willingness to Consult a Healthcare Provider Regarding Symptoms of Mild Cognitive Impairment. Am J Geriatr Psychiatry. 2016 Jul;24(7):537-46
[PubMed ID: 26809602]
Anderson ED Wahoske M Huber M Norton D Li Z Koscik RL Umucu E Johnson SC Jones J Asthana S Gleason CE . Cognitive variability-A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement (Amst). 2016 May 26;4:47-55
[PubMed ID: 27489880]
Kantarci K Lowe VJ Lesnick TG Tosakulwong N Bailey KR Fields JA Shuster LT Zuk SM Senjem ML Mielke MM Gleason C Jack CR Rocca WA Miller VM . Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition. J Alzheimers Dis. 2016 May 7;53(2):547-56
[PubMed ID: 27163830]
Hoscheidt SM Starks EJ Oh JM Zetterberg H Blennow K Krause RA Gleason CE Puglielli L Atwood CS Carlsson CM Asthana S Johnson SC Bendlin BB . Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults. J Alzheimers Dis. 2016 Apr 12;52(4):1373-83
[PubMed ID: 27079723]
Melah KE Lu SY Hoscheidt SM Alexander AL Adluru N Destiche DJ Carlsson CM Zetterberg H Blennow K Okonkwo OC Gleason CE Dowling NM Bratzke LC Rowley HA Sager MA Asthana S Johnson SC Bendlin BB . Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. J Alzheimers Dis. 2016;50(3):873-86
[PubMed ID: 26836182]
Gleason CE Dowling NM Wharton W Manson JE Miller VM Atwood CS Brinton EA Cedars MI Lobo RA Merriam GR Neal-Perry G Santoro NF Taylor HS Black DM Budoff MJ Hodis HN Naftolin F Harman SM Asthana S . Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Med. 2015 Jun 2;12(6):e1001833; discussion e1001833
[PubMed ID: 26035291]
Almeida RP Schultz SA Austin BP Boots EA Dowling NM Gleason CE Bendlin BB Sager MA Hermann BP Zetterberg H Carlsson CM Johnson SC Asthana S Okonkwo OC . Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease. JAMA Neurol. 2015 Jun;72(6):699-706
[PubMed ID: 25893879]
Dowling NM Johnson SC Gleason CE Jagust WJ . The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. Neuroimage. 2015 Jan 15;105:357-68
[PubMed ID: 25450107]
Gleason CE Fischer BL Dowling NM Setchell KD Atwood CS Carlsson CM Asthana S . Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease. J Alzheimers Dis. 2015;47(4):1009-19
[PubMed ID: 26401779]
Starks EJ Patrick O'Grady J Hoscheidt SM Racine AM Carlsson CM Zetterberg H Blennow K Okonkwo OC Puglielli L Asthana S Dowling NM Gleason CE Anderson RM Davenport-Sis NJ DeRungs LM Sager MA Johnson SC Bendlin BB . Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers. J Alzheimers Dis. 2015;46(2):525-33
[PubMed ID: 25812851]
Mielke MM Haughey NJ Bandaru VV Zetterberg H Blennow K Andreasson U Johnson SC Gleason CE Blazel HM Puglielli L Sager MA Asthana S Carlsson CM . Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease. Neurobiol Aging. 2014 Nov;35(11):2486-94
[PubMed ID: 24952994]
Fischer B Gleason C Asthana S . Effects of hormone therapy on cognition and mood. Fertil Steril. 2014 Apr;101(4):898-904
[PubMed ID: 24680649]
Fischer BL Gleason CE Gangnon RE Janczewski J Shea T Mahoney JE . Declining cognition and falls: role of risky performance of everyday mobility activities. Phys Ther. 2014 Mar;94(3):355-62
[PubMed ID: 24231226]
Wharton W Gleason CE Dowling NM Carlsson CM Brinton EA Santoro MN Neal-Perry G Taylor H Naftolin F Lobo RA Merriam G Manson JE Cedars MI Miller VM Black DM Budoff M Hodis HN Harman SM Asthana S . The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition. J Alzheimers Dis. 2014;40(2):331-41
[PubMed ID: 24430001]
Fischer BL Hoyt WT Maucieri L Kind AJ Gunter-Hunt G Swader TC Gangnon RE Gleason CE . Performance-based assessment of falls risk in older veterans with executive dysfunction. J Rehabil Res Dev. 2014;51(2):263-74
[PubMed ID: 24933724]